NPPNY
Price
$5.23
Change
+$0.04 (+0.77%)
Updated
Sep 18 closing price
Capitalization
1.51B
OVATF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
884.74K
Interact to see
Advertisement

NPPNY vs OVATF

Header iconNPPNY vs OVATF Comparison
Open Charts NPPNY vs OVATFBanner chart's image
Nippon Shinyaku
Price$5.23
Change+$0.04 (+0.77%)
Volume$288
Capitalization1.51B
Ovation Science
Price$0.03
Change-$0.00 (-0.00%)
Volume$2K
Capitalization884.74K
NPPNY vs OVATF Comparison Chart in %
Loading...
NPPNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NPPNY vs. OVATF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPPNY is a Hold and OVATF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (NPPNY: $5.23 vs. OVATF: $0.03)
Brand notoriety: NPPNY and OVATF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: NPPNY: 30% vs. OVATF: 35%
Market capitalization -- NPPNY: $1.51B vs. OVATF: $884.74K
NPPNY [@Pharmaceuticals: Generic] is valued at $1.51B. OVATF’s [@Pharmaceuticals: Generic] market capitalization is $884.74K. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NPPNY’s FA Score shows that 2 FA rating(s) are green whileOVATF’s FA Score has 0 green FA rating(s).

  • NPPNY’s FA Score: 2 green, 3 red.
  • OVATF’s FA Score: 0 green, 5 red.
According to our system of comparison, NPPNY is a better buy in the long-term than OVATF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NPPNY’s TA Score shows that 3 TA indicator(s) are bullish while OVATF’s TA Score has 3 bullish TA indicator(s).

  • NPPNY’s TA Score: 3 bullish, 4 bearish.
  • OVATF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, OVATF is a better buy in the short-term than NPPNY.

Price Growth

NPPNY (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while OVATF (@Pharmaceuticals: Generic) price change was -14.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NPPNY($1.51B) has a higher market cap than OVATF($885K). NPPNY YTD gains are higher at: -21.235 vs. OVATF (-35.500). NPPNY has higher annual earnings (EBITDA): 36.5B vs. OVATF (-402.84K). NPPNY has more cash in the bank: 66B vs. OVATF (5.55K). OVATF has less debt than NPPNY: OVATF (276K) vs NPPNY (2.55B). NPPNY has higher revenues than OVATF: NPPNY (154B) vs OVATF (64.7K).
NPPNYOVATFNPPNY / OVATF
Capitalization1.51B885K171,073%
EBITDA36.5B-402.84K-9,060,624%
Gain YTD-21.235-35.50060%
P/E Ratio6.44N/A-
Revenue154B64.7K238,021,638%
Total Cash66B5.55K1,190,046,881%
Total Debt2.55B276K924,275%
FUNDAMENTALS RATINGS
NPPNY vs OVATF: Fundamental Ratings
NPPNY
OVATF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
18100
PRICE GROWTH RATING
1..100
6265
P/E GROWTH RATING
1..100
70100
SEASONALITY SCORE
1..100
n/a55

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NPPNY's Valuation (6) in the null industry is somewhat better than the same rating for OVATF (63). This means that NPPNY’s stock grew somewhat faster than OVATF’s over the last 12 months.

NPPNY's Profit vs Risk Rating (100) in the null industry is in the same range as OVATF (100). This means that NPPNY’s stock grew similarly to OVATF’s over the last 12 months.

NPPNY's SMR Rating (18) in the null industry is significantly better than the same rating for OVATF (100). This means that NPPNY’s stock grew significantly faster than OVATF’s over the last 12 months.

NPPNY's Price Growth Rating (62) in the null industry is in the same range as OVATF (65). This means that NPPNY’s stock grew similarly to OVATF’s over the last 12 months.

NPPNY's P/E Growth Rating (70) in the null industry is in the same range as OVATF (100). This means that NPPNY’s stock grew similarly to OVATF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NPPNYOVATF
RSI
ODDS (%)
Bullish Trend 3 days ago
26%
Bullish Trend 3 days ago
43%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
33%
Bearish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
54%
MACD
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
52%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
27%
Bearish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
49%
Bullish Trend 3 days ago
37%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 3 days ago
26%
Bearish Trend 3 days ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
NPPNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXOZ15.480.91
+6.28%
eXoZymes Inc
IBCP31.530.17
+0.54%
Independent Bank Corp
ICUI118.810.55
+0.47%
ICU Medical
BBGI5.77-0.02
-0.41%
Beasley Broadcast Group Inc
GPN84.32-0.58
-0.68%
Global Payments

NPPNY and

Correlation & Price change

A.I.dvisor tells us that NPPNY and MKKGY have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NPPNY and MKKGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPPNY
1D Price
Change %
NPPNY100%
N/A
MKKGY - NPPNY
11%
Poorly correlated
+0.81%
MEDIF - NPPNY
11%
Poorly correlated
-2.58%
OVATF - NPPNY
9%
Poorly correlated
N/A
OMID - NPPNY
1%
Poorly correlated
+2.15%
MVMDF - NPPNY
-1%
Poorly correlated
N/A
More

OVATF and

Correlation & Price change

A.I.dvisor tells us that OVATF and KHTRF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OVATF and KHTRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVATF
1D Price
Change %
OVATF100%
N/A
KHTRF - OVATF
25%
Poorly correlated
N/A
KKPCF - OVATF
24%
Poorly correlated
N/A
BSPK - OVATF
20%
Poorly correlated
N/A
NPPNY - OVATF
9%
Poorly correlated
N/A
PCLOF - OVATF
5%
Poorly correlated
-42.30%
More